Measuring Aztreonam Variations by Process Analytical Technology

Aztreonam for injection (Fresenius Kabi) is a sterile, nonpyrogenic, sodium-free lyophilized, off-white to slightly yellow solid containing approximately 780 mg of arginine per gram of aztreonam, indicated for the treatment of specific infections caused by susceptible Gram-negative microorganisms. Ensuring the physical and chemical homogeneity of this lyophilized matrix is critical for consistent clinical efficacy; however, near-infrared (NIR) spectrometric screening coupled with high-dimensional principal component analysis (PCA) reveals complex, multidimensional inconsistencies within the commercially available product. Initial localized screening demonstrated significant intra-lot variability, with spectral data points forming a distinct toroidal pattern characteristic of cyclical oscillatory dynamics and an unstable mathematical average state. Extreme multidimensional outliers extending up to 5.6 standard deviations from the data centroid were observed diverging along multiple orthogonal trajectories, indicating that the intra-lot instability is driven by multiple independent physical and chemical mechanisms rather than a single processing failure. Expanding the evaluation to a comprehensive inter-lot analysis of 152 vials across 12 manufacturing lots confirmed that these inconsistencies persist at a systemic scale. The primary principal components divided the spectral library into two major, statistically distinct subpopulations, with asymmetric outlier distributions suggesting intermittent lapses in process control. Furthermore, projections in higher-order dimensions (PCs 7 through 9) isolated an entire manufacturing lot due to batch-level structural deviations possibly driven by trace moisture and aliphatic framework fluctuations. Nonparametric probability-density contour evaluations utilizing the FSOB algorithm and quantile-quantile (QQ) plots mathematically validated the presence of distinct subpopulations (r_tn=0.99, r_ts=0.88, p=0.02). Ultimately, these findings indicate that the manufacturing process is subjected to multiple, independent sources of instability, suggesting operations may intermittently fall outside a strict state of control.